Aims and Scope
The International Journal of Artificial Organs (IJAO) is the Official Journal of the European Society for Artificial Organs (ESAO).
The International Journal of Artificial Organs (IJAO) publishes monthly peer-reviewed research and clinical, experimental and theoretical, contributions to the field of artificial, bioartificial and tissue-engineered organs. The mission of the IJAO is to foster the development and optimization of artificial, bioartificial and tissue-engineered organs, for implantation or use in procedures, to treat functional deficits of all human tissues and organs.
The topics of interest range from the initial concept to clinical application, and are grouped in the following independent sections managed by highly qualified Editors:
Artificial Kidney and Detoxification Techniques
This section focuses on devices and procedures for blood detoxification processes using membranes or sorbents, such as hemodialysis, hemofiltration, hemodiafiltration, plasmapheresis, immune apheresis, leukoapheresis, and processes for plasma procurement and the preparation of plasma derivatives.
Cardiac Assist and Artificial Heart
This section deals with left ventricular assist devices, trans-apical by-pass, extracorporeal heart assist devices, total artificial heart, valve implants, vascular prostheses, and on organ perfusion equipment and techniques.
Artificial Lung and Respiratory Support
This section focuses on prostheses and procedures for the treatment of acute and chronic respiratory failure.
Artificial and Bioartificial Metabolic Prostheses and Support Systems
This section covers artificial and bioartificial tissues and organs. It comprises artificial prostheses to correct physical deficits (e.g., of the ear, eye, oesophagus, trachea, for mechanical support, etc.), as well as artificial and bioartificial organs to support natural organs with metabolic failure (e.g., liver, pancreas, etc. ).
Innovative and Affordable Artificial Organs and Pre-clinical Studies
This section focuses on innovative approaches to substitute for organ and tissue functions, and to contain costs to produce a prosthesis or assist patients, as well as on devices and procedures to assess the clinical feasibility of a prosthesis or a treatment prior to its actual use in the clinics (e.g., animal models and in vitro alternatives to their use).
Biomaterials and Nanotechnology
This section deals with the development, manufacturing, modification, and characterization of synthetic and natural materials with controlled properties down to the nanometer scale that make them capable of contacting body fluids for prosthetic and therapeutic applications.
This section focuses on the bioengineering aspects of artificial, bioartificial and tissue engineered prostheses and therapeutic treatments. It comprises from data acquisition and device control to blood fluid dynamics, and the design of separation devices and cell bioreactors.
Genomics, Proteomics, Metabolomics and Personalized Care
This section covers genomic, proteomic and metabolomic characterization of pathological conditions, and on how this information may be used to custom tailor treatments based on artificial, bioartificial and tissue engineered organs.
Tissue Engineering, Regenerative Medicine and Tissue Transplantation
This section focuses on the development, characterization and use of bioengineered tissues and organs, and on techniques to promote tissue or organ self-regeneration.
Musculo-Skeletal and Neural Prostheses
This section is devoted to prostheses meant to replace or augment physical human functions ranging from mechanical support, as in the case of musculoskeletal prostheses, to restoration and augmentation of sight or hearing functions, to neural signal transmission and brain-machine interfaces.